Bulk Inquiry
Peficitinib
- ASP015K - JNJ54781532
- Soluble in 0.1N HCl(aq) and DMSO
- MF: C18H22N4O2
- MW: 326.39
Description
Peficitinib is a potent and orally bioavailable JAK inhibitor with IC50 values of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and TYK2, respectively.
More Information
| Parent CAS No. | 944118-01-8 |
|---|---|
| Chemical Name | 4-[(trans-5-Hydroxyadamantan-2-yl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide |
| MFCD | MFCD28502035 |
| Short Description | JAK inhibitor |
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1338 | CP 690550 |
From $66.00 |
| 1378 | AG 490 |
From $71.50 |
| 1588 | TG 101348 |
From $88.00 |
| 1598 | Ruxolitinib |
From $71.50 |
| 1681 | Momelotinib |
From $88.00 |
| 1778 | AZ 960 |
From $104.50 |
| 1843 | JAK2 inhibitor 13 |
From $121.00 |
| 1955 | Baricitinib |
From $77.00 |
| 2072 | Tofacitinib citrate |
From $126.50 |
| 2217 | PF 956980 |
From $99.00 |
| 2219 | AT 9283 |
From $99.00 |
| 2231 | XL 019 |
From $110.00 |
| 2316 | WP 1066 |
From $104.50 |
| 2539 | Solcitinib |
From $99.00 |
| 2554 | LY 2784544 |
From $104.50 |
| 2775 | Cerdulatinib |
From $93.50 |
| 2792 | NVP-BSK805 |
From $137.50 |
| 3671 | CEP-33779 |
From $104.50 |
| 3813 | BMS-911543 |
From Inquiry |
| 3855 | AZD-4205 |
From Inquiry |
| 3861 | Decernotinib |
From Inquiry |
| 4091 | Deucravacitinib |
From $165.00 |
| 4124 | Momelotinib hydrochloride |
From $132.00 |
| 4386 | JAK inhibitor I |
From $143.00 |
